EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression



The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression



Contemporary Oncology 17(2): 113-119



Participation of fibrin, fibrinogen, and their degradation products in pathogenesis and progression of cancer may lead to complications of thromboembolic events. The tumor may be a source of fibrinogen. Fibrinogen inside the tumor is one of the factors of its growth and metastasis. Fibrinogen, fibrin and their degradation products possess proinflammatory activity. They indirectly stimulate endothelium to secrete von Willebrand factor, leading to activation of platelets accompanying neoplastic disorders. Fragments E and D are the end products of fibrin(ogen) degradation and E and DD are the end products of stabilized fibrin. E stimulates proliferation, migration and differentiation of endothelial cells, contributing to tumor vasculature. Increased levels of DD are observed in malignant neoplasms, such as breast, lung, colon and ovary cancers. In breast cancers DD correlates with progression of disease and metastasis. The role of fibrinogen and the products of its degradation in the progression of various tumors is not sufficiently understood.

(PDF same-day service: $19.90)

Accession: 056477042

Download citation: RISBibTeXText

PMID: 23788975

DOI: 10.5114/wo.2013.34611



Related references

Use of monoclonal antibodies to fibrinogen, fibrin and fibrin (ogen) degradation products in atherosclerosis. NATO ASI series Series A Life sciences19(219): 189-197, 1991

Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 9(1): 109-121, 1989

Role of proteases plasminogen activators fibrinogen fibrin degradation products fibrin and fibrinopeptides on tumor growth metastasis. Postepy Higieny i Medycyny Doswiadczalnej 38(2): 133-156, 1984

Soluble fibrin (ethanol gelation test) and fibrin(ogen) degradation products in suspected thrombosis with reference to the 125I-fibrinogen uptake test for detection of thrombus formation. European Journal of Haematology 31(S39): 65-74, 1983

Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test). Folia Haematologica 106(5-6): 967-970, 1979

Transitory influence of fibrinogen fibrin degradation products fdps on platelet aggregation. Thrombosis & Haemostasis 58(1): 472, 1987

Ca binding of rat fibrinogen and fibrin(ogen) degradation products. Febs Letters 93(1): 177-180, 1978

Fibrinogen, fibrin(ogen) degradation products and fibrinopeptide A in pleural effusions. High turnover of fibrinogen in pleurisy. Scandinavian Journal of Respiratory Diseases 59(4): 210-215, 1978

Comparison of the potentiating effect of fibrinogen fibrinogen degradation products and fibrin degradation products on the amidolytic activity of the plasminogen strepto kinase complex improvement of plasminogen determination in biological samples by decreasing the influence of fibrin degradation products. Thrombosis & Haemostasis 50(1): 56, 1983

Effect of fibrinogen, fibrin and fibrin ogen degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system. Zhonghua Xinxueguanbing Zazhi 36(1): 62-67, 2008

Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system. Zhonghua Xin Xue Guan Bing Za Zhi 36(1): 62-67, 2009

D-dimer and its relationship to fibrinogen/fibrin degradation products (FDPs) in disorders associated with activation of coagulation or fibrinolytic systems. Journal of Clinical Laboratory Analysis 17(3): 77-79, 2003

Measuring plasma fibrinogen levels in patients with liver cirrhosis: The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays. Thrombosis Research 78(4): 353-362, 1995

Enhancement of amidolytic activity on chromogenic substrate of strepto kinase plasminogen complex induced by fibrin degradation products comparison of potentiator activity between fibrinogen fibrinogen degradation products d or e and fibrin split products early and late stages. Haemostasis 11(SUPPL 1): 98, 1982

Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC. Rinsho Byori. Japanese Journal of Clinical Pathology 41(12): 1349-1352, 1993